Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.12%.

  • Cumberland Pharmaceuticals' Return on Invested Capital rose 2600.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.22% for FY2024, which is 700.0% up from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Return on Invested Capital is 0.12%, which was up 2600.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Return on Invested Capital ranged from a high of 0.1% in Q2 2021 and a low of 0.41% during Q2 2024
  • Its 5-year average for Return on Invested Capital is 0.19%, with a median of 0.17% in 2023.
  • In the last 5 years, Cumberland Pharmaceuticals' Return on Invested Capital plummeted by -2900bps in 2024 and then skyrocketed by 3000bps in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.17% in 2021, then increased by 11bps to 0.15% in 2022, then crashed by -91bps to 0.29% in 2023, then rose by 26bps to 0.22% in 2024, then surged by 45bps to 0.12% in 2025.
  • Its Return on Invested Capital stands at 0.12% for Q3 2025, versus 0.1% for Q2 2025 and 0.11% for Q1 2025.